Pacer Advisors Inc. Acquires 144 Shares of Chemed Co. (NYSE:CHE)

Pacer Advisors Inc. grew its holdings in Chemed Co. (NYSE:CHE) by 4.4% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,407 shares of the company’s stock after purchasing an additional 144 shares during the period. Pacer Advisors Inc.’s holdings in Chemed were worth $1,849,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in CHE. Rise Advisors LLC bought a new position in Chemed in the first quarter valued at $26,000. GAMMA Investing LLC grew its holdings in shares of Chemed by 34.4% in the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after acquiring an additional 22 shares in the last quarter. Mather Group LLC. acquired a new stake in shares of Chemed in the first quarter valued at about $67,000. EntryPoint Capital LLC raised its holdings in Chemed by 14.0% during the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after acquiring an additional 18 shares in the last quarter. Finally, Janiczek Wealth Management LLC boosted its position in Chemed by 154.5% during the first quarter. Janiczek Wealth Management LLC now owns 196 shares of the company’s stock valued at $126,000 after purchasing an additional 119 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Up 0.3 %

CHE stock opened at $595.51 on Thursday. The company has a market cap of $9.02 billion, a price-to-earnings ratio of 32.05, a P/E/G ratio of 2.40 and a beta of 0.44. Chemed Co. has a twelve month low of $497.36 and a twelve month high of $654.62. The business has a 50 day moving average price of $572.25 and a two-hundred day moving average price of $576.61.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing the consensus estimate of $5.59 by ($0.12). The firm had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. Chemed’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the business posted $4.71 earnings per share. On average, equities research analysts anticipate that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. This is a boost from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s dividend payout ratio is presently 10.76%.

Insider Buying and Selling

In other Chemed news, EVP Nicholas Michael Westfall sold 1,713 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $569.35, for a total value of $975,296.55. Following the sale, the executive vice president now owns 6,109 shares in the company, valued at $3,478,159.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, Director George J. Walsh III sold 200 shares of Chemed stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the sale, the director now owns 3,446 shares of the company’s stock, valued at approximately $1,991,615.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $569.35, for a total transaction of $975,296.55. Following the completion of the transaction, the executive vice president now directly owns 6,109 shares in the company, valued at $3,478,159.15. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,744 shares of company stock worth $3,828,231. Company insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.